In a subterranean lab at the far corner of Columbia University’s main New York City campus, a couple of men in lab coats and safety glasses discuss a problem in their research. Across the hall, a woman attired similarly is at work in the machine shop. Glassware, chemicals in jugs, tubing and various equipment cover what seems like every corner of bench space.
These people are part of Samuel Sia’s 30-member crack team of chemists, biologists and engineers. Sia, a biomedical engineer, has gathered them together to help foment a medical revolution.
Their idea: to outsource to individuals and family doctors the tests that are now the exclusive domain of centralized labs and hospitals. Their weapons are a new crop of coming diagnostic technologies that are smaller, cheaper and smarter than anything on the market today. Inherent to this change in the business model is the jailbreak of patients’ medical data from healthcare facilities and insurance companies back to the patient and doctor from where it came.
“Whenever we want to know about our own body, we have to go through the healthcare system,” Sia tells Txchnologist. “You shouldn’t have to do that. Are you vitamin deficient? Do you have the flu? Are you trying to get pregnant? What is that new Mediterranean diet doing to your body? You should be able to monitor your own body, but right now it’s out of your hands.”